Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 85.00 |
Description | Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats. |
Synonyms | Bifeprunox, DU 127090, DU-127090, DU127090 |
Molecular Weight | 481.56 |
Formula | C25H27N3O5S |
CAS No. | 350992-13-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bifeprunox Mesylate 350992-13-1 Bifeprunox DU 127090 DU-127090 DU127090 inhibitor inhibit